drugset
drugset / Trial / NCT06378684

To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers

NCT06378684 ↗

Phase 1 Completed 48 enrolled JW Pharmaceutical
RandomizedSequentialOpen-labelOther

Summary

The objective is to evaluate the safety and Pharmacokinetic Interactions after adminitration drug(Treatment A or B or A+B) in Healthy Volunteers

Timeline

Start
2023-09-10
Primary completion
2023-12-23
Completion
2024-01-13

Drugs

EvaluationDrugModalityDoseRoute
Subject C2207 Unknown — Oral
Subject JW0104 Unknown — Oral

Indications

No indication recorded.